Similar results were observed also in advanced HCC, where the count of CD8+T cells in TILs was lower in patients with metastatic disease than in those without [47] and the ability of specific subsets of T cells in HCC was claimed to be able to predict extrahepatic metastasis and prognosis [48,49]. The gene discussed is CD8A; the disease is metastatic neoplasm.